Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$7.12 – $14.62
10% from low
Exchange
OTC Link
ADRC
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.42B | $2.67B | $3.12B | $3.38B | $3.59B | $3.67B | $3.98B | $4.07B |
| Cost of revenue | $1.14B | $1.23B | $1.38B | $1.41B | $1.63B | $1.62B | $1.76B | $1.73B |
| Gross profit | $1.28B | $1.45B | $1.74B | $1.97B | $1.96B | $2.06B | $2.22B | $2.18B |
| Gross margin | 53.1% | 54.2% | 55.7% | 58.3% | 54.6% | 56.0% | 55.7% | 53.7% |
| R&D | $325.5M | $372.5M | $395.7M | $385.8M | $446.6M | $540.3M | $491.5M | $487.4M |
| Operating income | $318.0M | $330.9M | $551.2M | $784.3M | $587.2M | $439.0M | $588.8M | $694.7M |
| EBITDA | $517.3M | $558.9M | $796.5M | $1.01B | $852.6M | $857.8M | $897.5M | $848.6M |
| Net income | $256.5M | $272.8M | $404.4M | $601.1M | $452.3M | $357.6M | $432.2M | $381.8M |
| Net margin | 10.6% | 10.2% | 13.0% | 17.8% | 12.6% | 9.7% | 10.9% | 9.4% |
| EPS (diluted) | 0.22 | 0.23 | 0.34 | 0.51 | 0.38 | 0.30 | 0.36 | 0.32 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $4.1B | $0.00 | $0.00–$0.00 | 0 |
| 2027 | $4.4B | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
BIOMERIEUX S A UNSP/ADR
No one on the platform currently holds BMXXY.
No tracked institution reports a position in BMXXY as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-10 | $0.1128 | 2026-06-26 |
| 2025-06-10 | $0.1032 | 2025-06-26 |
| 2024-06-10 | $0.0910 | 2024-06-26 |
No one on the platform has traded BMXXY yet.
| $23.2B |
| — |
| SAUHFStraumann Holding AG | $133.72 | +0.00% | $21.3B | — |
| SAUHYStraumann Holding AG | $13.15 | -0.45% | $21.0B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 11.6× earnings vs its 41.6× historical median P/E.
Fair value ≈ $28.29 · price $7.88 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.